Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

Conclusions. Biomarkers can be used safely as part of a multidisciplinary approach to the diagnosis of IFD in neutropaenic haemato-oncology patients. Whilst they do not necessarily result in antifungal therapy being withheld, they can allow more confident diagnosis of IFD and more specific antifungal therapy in selected cases.PMID:35819894 | DOI:10.1099/jmm.0.001564

Source: Journal of Medical Microbiology - July 12, 2022 Category: Microbiology Authors: Anthony W Martinelli Callum B Wright Marta S Lopes Rosemary L Swayne Pramila Krishnamurthy Charles Crawley Ben Uttenthal George Follows Judith Babar Sani H Aliyu David A Enoch Clare R Sander Source Type: research